| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5581678 | Clinical Lymphoma Myeloma and Leukemia | 2016 | 7 Pages |
Abstract
A majority (71%) of DLBCL relapses after auto-HCT are detected by routine surveillance imaging. Overall, there appears to be limited utility for routine imaging after auto-HCT except in select cases where earlier detection and salvage therapy with allogeneic HCT is a potential option.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Narendranath Epperla, Namrata Shah, Mehdi Hamadani, Kristin Richardson, Jonathan T. Kapke, Asmita Patel, Sravanthi P. Teegavarapu, George Carrum, Parameswaran N. Hari, Sai R. Pingali, Reem Karmali, Timothy S. Fenske,